Colignon Ward B MD is categorized under Internal Medicine Doctors in Bremerton, WA and active since 1974.
Colignon Ward B MD was established in 1974, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Ward Colignon at the company’s single location by writing to 2601 Cherry Avenue # 315, Bremerton, Washington WA 98310 or by phoning (360) 377-8571. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Colignon Ward B MD |
| Contact Person: | Ward Colignon |
| Address: | 2601 Cherry Avenue # 315, Bremerton, Washington 98310 |
| Phone Number: | (360) 377-8571 |
| Website Address: | americanchemical.net |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1974 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Colignon Ward B MD was started in 1974 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Ward Colignon for inquiries that concern Colignon Ward B MD by calling the company number (360) 377-8571, as your correspondence is most welcome. Additionally, the physical location of the single location of Colignon Ward B MD can be found at the coordinates 47.5845,-122.62595 as well as the street address 2601 Cherry Avenue # 315 in Bremerton, Washington 98310.
For its online presence, you may visit Colignon Ward B MD’s website at americanchemical.net and engage with its social media outlets through on Twitter and on Facebook.